Dorota Tomalik-Scharte
Department of Pharmacology
Clinical Pharmacology
University of Cologne
Gleueler Straße 24
Germany
Name/email consistency: high
- Effect of the CYP2C8 Genotype on the Pharmacokinetics and Pharmacodynamics of Repaglinide. Tomalik-Scharte, D., Fuhr, U., Hellmich, M., Frank, D., Doroshyenko, O., Jetter, A., Stingl, J.C. Drug Metab. Dispos. (2011)
- Plasma 4beta-hydroxycholesterol: an endogenous CYP3A metric? Tomalik-Scharte, D., Lütjohann, D., Doroshyenko, O., Frank, D., Jetter, A., Fuhr, U. Clin. Pharmacol. Ther. (2009)
- The clinical role of genetic polymorphisms in drug-metabolizing enzymes. Tomalik-Scharte, D., Lazar, A., Fuhr, U., Kirchheiner, J. Pharmacogenomics J. (2008)
- Effect of propiverine on cytochrome P450 enzymes: a cocktail interaction study in healthy volunteers. Tomalik-Scharte, D., Jetter, A., Kinzig-Schippers, M., Skott, A., Sörgel, F., Klaassen, T., Kasel, D., Harlfinger, S., Doroshyenko, O., Frank, D., Kirchheiner, J., Bräter, M., Richter, K., Gramatté, T., Fuhr, U. Drug Metab. Dispos. (2005)